A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer - Sorbonne Université Access content directly
Journal Articles Gynecologic Oncology Year : 2023

A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer

Félix Blanc-Durand
  • Function : Author
Elisa Yaniz-Galende
  • Function : Author
Alba Llop-Guevara
  • Function : Author
Catherine Genestie
  • Function : Author
Violeta Serra
  • Function : Author
Andrea Herencia-Ropero
  • Function : Author
Dominique Berton
  • Function : Author
Alain Lortholary
  • Function : Author
Nadine Dohollou
  • Function : Author
Christophe Desauw
  • Function : Author
Michel Fabbro
  • Function : Author
Emmanuelle Malaurie
  • Function : Author
Nathalie Bonichon-Lamaichhane
  • Function : Author
Coraline Dubot
  • Function : Author
Jean Emmanuel Kurtz
  • Function : Author
Gaëtan de Rauglaudre
  • Function : Author
Nadia Raban
  • Function : Author
Annick Chevalier-Place
  • Function : Author
Gwenael Ferron
  • Function : Author
Marie-Christine Kaminsky
  • Function : Author
Claire Kramer
  • Function : Author
Etienne Rouleau
  • Function : Author
Alexandra Leary
  • Function : Author

Domains

Cancer
No file

Dates and versions

hal-04210315 , version 1 (18-09-2023)

Identifiers

Cite

Félix Blanc-Durand, Elisa Yaniz-Galende, Alba Llop-Guevara, Catherine Genestie, Violeta Serra, et al.. A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer. Gynecologic Oncology, 2023, 171, pp.106-113. ⟨10.1016/j.ygyno.2023.01.026⟩. ⟨hal-04210315⟩
4 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More